Gimsilumab
Gimsilumab (MORAb-022) is a humanized monoclonal antibody targeting granulocyte macrophage colony-stimulating factor for the study of COVID-19-induced inflammation and hypoxemia.
Product Specifications
CAS Number
1648796-29-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
C-Fms | SARS-CoV
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
36819-05141 2x 75 µg
Human C1 esterase inhibitor AssayLite™ Antibody (FITC Conjugate)
Sign In for Pricing
View Details RG205080 10 µg
Peroxiredoxin 3 (PRDX3) (NM_006793) Human Tagged ORF Clone
Sign In for Pricing
View Details 